Search
for
Sort by
Research 421–450 of 1000+
- Androgenic Efficacy and Mechanism of Glycosides-Based Standardized Fenugreek Seeds Extract Through Aromatase And 5-Alpha Reductase Inhibition
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- 90 Exploring the therapeutic potential of DHODH inhibitor farudodstat for alopecia areata treatment in a novel ex vivo model of human hair follicle immune privilege collapse
- Hidradenitis suppurativa secondary to treatment with a gamma secretase inhibitor
- SAT340 Matters Of The HAART - Ritonavir Induced CYP3A4 Inhibition of Intranasal Fluticasone Leading To Cushing’s Syndrome
- LB1777 A novel ex vivo model of human hair follicle immune privilege collapse reveals the potential of farudodstat, a DHODH inhibitor, as a therapeutic for alopecia areata treatment
- Janus Kinase inhibitors in dermatology: a review
- Epidermal Growth Factor Receptor Inhibitor–Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema: Should You Discontinue the Offending Agent?
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- The steroidogenic inhibitor finasteride reverses pramipexole-induced alterations in probability discounting
- Aromatase inhibitor–induced hair loss in two adolescents
- Comment on ‘Androgenetic alopecia is associated with increased scalp hardness’: role of phosphodiesterase inhibitors?
- The effects of phosphodiesterase 3 (PDE3) inhibitor on hair follicle cell viability and hair growth
- Melanotic pigmentation in excisional scar of melanoma patient who received BRAF and MEK inhibitors
- 1072 Promotion of hair growth in normal mouse skin and alopecia areata by topical treatment of HDAC inhibitors
- Janus kinase inhibitors for the use of alopecia areata: A promising therapeutic of the future
- Mitigation of epidermal growth factor receptor inhibitor-induced side effects utilizing melanin and vascular-specific lasers: A case report series
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- 378 Treatment of severe alopecia areata with the oral Janus kinase inhibitor, tofacitinib: A retrospective chart review
- A New Era of 5α-Reductase Inhibitors for Androgenetic Alopecia
- [Visual field defect in a patient given sodium valporate then carbamazepine: possible effect of aminotransferase inhibition].
- Growth inhibition of mouse skin tumor by serine protease inhibitor ONO-3403.
- Selective inhibition of glucuronidation and sulfation in vitro and in vivo
- [Ovulation inhibition in the treatment of androgenic alopecia in woemn].
- Œdème angioneurotique sans anomalie de l’inhibiteur de la C1 estérase : efficacité de l’acide tranexamique
- Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers
- Real‐World Outcomes and Safety of JAK Inhibitors in Paediatric Alopecia Areata: A Retrospective Multicentre Study
- Relapse of alopecia areata during ongoing Janus kinase inhibitor therapy is not uncommon and usually occurs in previously affected areas: A multicenter Italian real-world study
- Efficacy and Safety of Oral Janus Kinase Inhibitors in Adults and Adolescents with Alopecia Areata: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA